pulmonary

(redirected from pulmonary alveolar proteinosis)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

pulmonary

1. of, or relating to or affecting the lungs
2. having lungs or lunglike organs
References in periodicals archive ?
Tazawa et al., "Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis," CHEST, vol.
Technique of lung isolation for whole lung lavage in a child with pulmonary alveolar proteinosis. Anesthesiology 2009; 110: 190-2.
Pulmonary alveolar proteinosis induced by silica dust.
The various aetiologies evolved from our study were ABPA (5 cases), BOOP (2 cases), Pulmonary alveolar proteinosis (1 case), Strongyloides (1 case), Amiodarone pneumonitis (1 case), Wegener's granulomatosis (1 case), Acute myeloid leukaemia (1 case) and so on.
Seethamraju, "Pulmonary alveolar proteinosis: a rare pulmonary toxicity of sirolimus in lung transplant patients," Chest, vol.
The terms used to describe the ILD event included pneumonitis, interstitial pneumonitis, organizing pneumonia, lymphocytic pneumonitis, lymphocytic alveolitis, pulmonary alveolar proteinosis, infiltrative pneumonia, alveolitis obliterans, allergic pneumonitis, interstitial granulomatous pneumonitis, and bronchiolitis obliterans.
They address diseases like Marfan and Goodpasture's syndromes, sarcoidosis, autoimmune pulmonary alveolar proteinosis, hereditary haemorrhagic telangiectasia, Hermansky-Pudlak syndrome, primary ciliary dyskinesia, cystic fibrosis, scleroderma lung disease, and alpha-1 antitrypsin deficiency, and their epidemiology, genetic basis and molecular pathogenesis, animal models, clinical presentation, diagnosis, conventional management and treatment strategies, and future therapies and directions.
(4) This is speculated to lead to inhibition of lipid degradation and surfactant turnover, a mechanism similarly implicated in pulmonary alveolar proteinosis. (10) Alternatively, a hypersensitivity response to the drug may develop, resulting in indirect lung injury.
Role of physical therapy in management of pulmonary alveolar proteinosis. Physical Therapy, 68(5), 686-689.
M2 PHARMA-May 8, 2019-Molgradex Received Fast Track Designation by FDA for Treatment of Autoimmune Pulmonary Alveolar Proteinosis
Molgradex is also being investigated in a global pivotal Phase 3 clinical study, called IMPALA, for the treatment of autoimmune pulmonary alveolar proteinosis. Enrollment in the study is complete and top line results are expected in Q2of 2019.
Pulmonary alveolar proteinosis is the prototype of airspace diseases that can be sampled by transbronchial lung biopsy (Figure 12, A and B).

Full browser ?